← Back to Search

Partially Hydrolyzed Whey Protein-Based Formula

Study Infant Formula for Gastrointestinal Tolerance

N/A
Waitlist Available
Research Sponsored by Abbott Nutrition
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up sday 1 to sday 28
Awards & highlights

Study Summary

This study is evaluating whether a formula with a different protein source and different carbohydrate content can reduce symptoms of formula intolerance in healthy infants.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~sday 1 to sday 28
This trial's timeline: 3 weeks for screening, Varies for treatment, and sday 1 to sday 28 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Fussiness
Secondary outcome measures
Gastrointestinal Tolerance
Stool
Other outcome measures
Adverse Events
Formula Intake
Formula Satisfaction Questionnaire
+5 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Study Infant FormulaExperimental Treatment1 Intervention
Feed ad libitum during study period

Find a Location

Who is running the clinical trial?

Abbott NutritionLead Sponsor
168 Previous Clinical Trials
33,486 Total Patients Enrolled
John Lasekan, PhD, MS, MBA, CCRPStudy ChairAbbott Nutrition

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Apr 2025